Are commercial warming kits interchangeable for vitrified human blastocysts? Further evidence for the adoption of a Universal Warming protocol
Purpose To study whether a new combination of different warming kits is clinically effective for vitrified human blastocysts. Methods This is a longitudinal cohort study analysing two hundred fifty-five blastocysts warming cycles performed between January and October 2018. Embryos were vitrified usi...
Gespeichert in:
Veröffentlicht in: | Journal of assisted reproduction and genetics 2022-01, Vol.39 (1), p.67-73 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 73 |
---|---|
container_issue | 1 |
container_start_page | 67 |
container_title | Journal of assisted reproduction and genetics |
container_volume | 39 |
creator | Canosa, Stefano Parmegiani, Lodovico Charrier, Lorena Gennarelli, Gianluca Garello, Cristina Granella, Francesca Evangelista, Francesca Monelli, Giuseppe Guidetti, Daniela Revelli, Alberto Filicori, Marco Bongioanni, Francesca |
description | Purpose
To study whether a new combination of different warming kits is clinically effective for vitrified human blastocysts.
Methods
This is a longitudinal cohort study analysing two hundred fifty-five blastocysts warming cycles performed between January and October 2018. Embryos were vitrified using only one brand of ready-to-use kits (Kitazato), whereas the warming procedure was performed with three of the most widely used vitrification/warming kits (Kitazato, Sage and Irvine) after patient stratification for oocyte source. The primary endpoint was survival rate, while the secondary endpoints were clinical pregnancy, live birth and miscarriage rates.
Results
We observed a comparable survival rate across all groups of 100% (47/47) in KK, 97.6% (49/50) in KS, 97.6% (41/42) in KI, 100% (38/38) in dKK, 100% (35/35) in dKS and 100% (43/43) in dKI. Clinical pregnancy rates were also comparable: 38.3% (18/47) in KK, 49% (24/49) in KS, 56.1% (23/ 41) in KI, 47.4% (18/38) in dKK, 31.4% (11/35) in dKS and 48.8% (21/ 43) in dKI. Finally, live birth rates were 29.8% (14/47) in KK, 36.7% (18/49) in KS, 46.3% (19/41) in KI, 36.8% (14/38) in dKK, 25.7% (9/35) in dKS and 41.9% (18/43) in dKI, showing no significant differences.
Conclusion
This study confirmed the efficacy of applying a single warming protocol, despite what the “industry” has led us to believe, supporting the idea that it is time to proceed in the cryopreservation field and encouraging embryologists worldwide to come out and reveal that such a procedure is possible and safe. |
doi_str_mv | 10.1007/s10815-021-02364-1 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8866604</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2632034741</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-77772b4d8d345180c47d54f721a56f601656cdbe72f3bdee688c65ebebd8e7883</originalsourceid><addsrcrecordid>eNp9kU2LFDEQhhtR3A_9Ax4k4MVLa9L56MxFWRZXhQUvLh5DOqmeydqdjEl6ZP-Ev3lrnXH9OBgIKaqeeivF2zTPGH3FKO1fF0Y1ky3tGF6uRMseNMdM9rztOacPMaZSt1QofdSclHJNKV3pjj9ujrjQQspeHTc_zjIQl-YZsgt2It9tnkNck6-hFhJixfTGxjXYYQIypkx2oeYwBvBks8w2kmGypSZ3U2p5Sy6WXDeQCeyCh-j2HZgh1qdtDSmSNBJLrmLYQS447sth3DYnFEnTk-bRaKcCTw_vaXN18e7z-Yf28tP7j-dnl60Tvahtj6cbhNeeC8k0xayXYuw7ZqUaFWVKKucH6LuRDx5Aae2UhAEGr6HXmp82b_a622WYwTuINdvJbHOYbb4xyQbzdyWGjVmnndFaKUUFCrw8COT0bYFSzRyKg2myEdJSTIeQ5nS1Uoi--Ae9TkuOuB5SvKMcV2JIdXvK5VRKhvH-M4yaO7vN3m6Ddpufdpu7pud_rnHf8stfBPgeKFhCG_Pv2f-RvQWDH7l0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2632034741</pqid></control><display><type>article</type><title>Are commercial warming kits interchangeable for vitrified human blastocysts? Further evidence for the adoption of a Universal Warming protocol</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>SpringerLink Journals - AutoHoldings</source><creator>Canosa, Stefano ; Parmegiani, Lodovico ; Charrier, Lorena ; Gennarelli, Gianluca ; Garello, Cristina ; Granella, Francesca ; Evangelista, Francesca ; Monelli, Giuseppe ; Guidetti, Daniela ; Revelli, Alberto ; Filicori, Marco ; Bongioanni, Francesca</creator><creatorcontrib>Canosa, Stefano ; Parmegiani, Lodovico ; Charrier, Lorena ; Gennarelli, Gianluca ; Garello, Cristina ; Granella, Francesca ; Evangelista, Francesca ; Monelli, Giuseppe ; Guidetti, Daniela ; Revelli, Alberto ; Filicori, Marco ; Bongioanni, Francesca</creatorcontrib><description>Purpose
To study whether a new combination of different warming kits is clinically effective for vitrified human blastocysts.
Methods
This is a longitudinal cohort study analysing two hundred fifty-five blastocysts warming cycles performed between January and October 2018. Embryos were vitrified using only one brand of ready-to-use kits (Kitazato), whereas the warming procedure was performed with three of the most widely used vitrification/warming kits (Kitazato, Sage and Irvine) after patient stratification for oocyte source. The primary endpoint was survival rate, while the secondary endpoints were clinical pregnancy, live birth and miscarriage rates.
Results
We observed a comparable survival rate across all groups of 100% (47/47) in KK, 97.6% (49/50) in KS, 97.6% (41/42) in KI, 100% (38/38) in dKK, 100% (35/35) in dKS and 100% (43/43) in dKI. Clinical pregnancy rates were also comparable: 38.3% (18/47) in KK, 49% (24/49) in KS, 56.1% (23/ 41) in KI, 47.4% (18/38) in dKK, 31.4% (11/35) in dKS and 48.8% (21/ 43) in dKI. Finally, live birth rates were 29.8% (14/47) in KK, 36.7% (18/49) in KS, 46.3% (19/41) in KI, 36.8% (14/38) in dKK, 25.7% (9/35) in dKS and 41.9% (18/43) in dKI, showing no significant differences.
Conclusion
This study confirmed the efficacy of applying a single warming protocol, despite what the “industry” has led us to believe, supporting the idea that it is time to proceed in the cryopreservation field and encouraging embryologists worldwide to come out and reveal that such a procedure is possible and safe.</description><identifier>ISSN: 1058-0468</identifier><identifier>EISSN: 1573-7330</identifier><identifier>DOI: 10.1007/s10815-021-02364-1</identifier><identifier>PMID: 34845576</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Adult ; Birth rate ; Blastocysts ; Blastomeres - cytology ; Blastomeres - physiology ; Cohort Studies ; Cryopreservation ; Embryo Transfer - methods ; Embryology ; Embryos ; Female ; Gynecology ; Hot Temperature - therapeutic use ; Human Genetics ; Humans ; In vitro fertilization ; Laboratories ; Longitudinal Studies ; Male ; Medicine ; Medicine & Public Health ; Middle Aged ; Oocytes - cytology ; Oocytes - parasitology ; Opinion ; Ovaries ; Pregnancy ; Reproductive Medicine ; Sperm ; Survival ; Vitrification</subject><ispartof>Journal of assisted reproduction and genetics, 2022-01, Vol.39 (1), p.67-73</ispartof><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021</rights><rights>2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</rights><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-77772b4d8d345180c47d54f721a56f601656cdbe72f3bdee688c65ebebd8e7883</citedby><cites>FETCH-LOGICAL-c474t-77772b4d8d345180c47d54f721a56f601656cdbe72f3bdee688c65ebebd8e7883</cites><orcidid>0000-0003-4390-9428 ; 0000-0001-6402-6750 ; 0000-0002-1300-4508 ; 0000-0002-5797-3722 ; 0000-0003-4995-0317 ; 0000-0003-3901-885X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866604/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866604/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,41464,42533,51294,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34845576$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Canosa, Stefano</creatorcontrib><creatorcontrib>Parmegiani, Lodovico</creatorcontrib><creatorcontrib>Charrier, Lorena</creatorcontrib><creatorcontrib>Gennarelli, Gianluca</creatorcontrib><creatorcontrib>Garello, Cristina</creatorcontrib><creatorcontrib>Granella, Francesca</creatorcontrib><creatorcontrib>Evangelista, Francesca</creatorcontrib><creatorcontrib>Monelli, Giuseppe</creatorcontrib><creatorcontrib>Guidetti, Daniela</creatorcontrib><creatorcontrib>Revelli, Alberto</creatorcontrib><creatorcontrib>Filicori, Marco</creatorcontrib><creatorcontrib>Bongioanni, Francesca</creatorcontrib><title>Are commercial warming kits interchangeable for vitrified human blastocysts? Further evidence for the adoption of a Universal Warming protocol</title><title>Journal of assisted reproduction and genetics</title><addtitle>J Assist Reprod Genet</addtitle><addtitle>J Assist Reprod Genet</addtitle><description>Purpose
To study whether a new combination of different warming kits is clinically effective for vitrified human blastocysts.
Methods
This is a longitudinal cohort study analysing two hundred fifty-five blastocysts warming cycles performed between January and October 2018. Embryos were vitrified using only one brand of ready-to-use kits (Kitazato), whereas the warming procedure was performed with three of the most widely used vitrification/warming kits (Kitazato, Sage and Irvine) after patient stratification for oocyte source. The primary endpoint was survival rate, while the secondary endpoints were clinical pregnancy, live birth and miscarriage rates.
Results
We observed a comparable survival rate across all groups of 100% (47/47) in KK, 97.6% (49/50) in KS, 97.6% (41/42) in KI, 100% (38/38) in dKK, 100% (35/35) in dKS and 100% (43/43) in dKI. Clinical pregnancy rates were also comparable: 38.3% (18/47) in KK, 49% (24/49) in KS, 56.1% (23/ 41) in KI, 47.4% (18/38) in dKK, 31.4% (11/35) in dKS and 48.8% (21/ 43) in dKI. Finally, live birth rates were 29.8% (14/47) in KK, 36.7% (18/49) in KS, 46.3% (19/41) in KI, 36.8% (14/38) in dKK, 25.7% (9/35) in dKS and 41.9% (18/43) in dKI, showing no significant differences.
Conclusion
This study confirmed the efficacy of applying a single warming protocol, despite what the “industry” has led us to believe, supporting the idea that it is time to proceed in the cryopreservation field and encouraging embryologists worldwide to come out and reveal that such a procedure is possible and safe.</description><subject>Adult</subject><subject>Birth rate</subject><subject>Blastocysts</subject><subject>Blastomeres - cytology</subject><subject>Blastomeres - physiology</subject><subject>Cohort Studies</subject><subject>Cryopreservation</subject><subject>Embryo Transfer - methods</subject><subject>Embryology</subject><subject>Embryos</subject><subject>Female</subject><subject>Gynecology</subject><subject>Hot Temperature - therapeutic use</subject><subject>Human Genetics</subject><subject>Humans</subject><subject>In vitro fertilization</subject><subject>Laboratories</subject><subject>Longitudinal Studies</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>Oocytes - cytology</subject><subject>Oocytes - parasitology</subject><subject>Opinion</subject><subject>Ovaries</subject><subject>Pregnancy</subject><subject>Reproductive Medicine</subject><subject>Sperm</subject><subject>Survival</subject><subject>Vitrification</subject><issn>1058-0468</issn><issn>1573-7330</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp9kU2LFDEQhhtR3A_9Ax4k4MVLa9L56MxFWRZXhQUvLh5DOqmeydqdjEl6ZP-Ev3lrnXH9OBgIKaqeeivF2zTPGH3FKO1fF0Y1ky3tGF6uRMseNMdM9rztOacPMaZSt1QofdSclHJNKV3pjj9ujrjQQspeHTc_zjIQl-YZsgt2It9tnkNck6-hFhJixfTGxjXYYQIypkx2oeYwBvBks8w2kmGypSZ3U2p5Sy6WXDeQCeyCh-j2HZgh1qdtDSmSNBJLrmLYQS447sth3DYnFEnTk-bRaKcCTw_vaXN18e7z-Yf28tP7j-dnl60Tvahtj6cbhNeeC8k0xayXYuw7ZqUaFWVKKucH6LuRDx5Aae2UhAEGr6HXmp82b_a622WYwTuINdvJbHOYbb4xyQbzdyWGjVmnndFaKUUFCrw8COT0bYFSzRyKg2myEdJSTIeQ5nS1Uoi--Ae9TkuOuB5SvKMcV2JIdXvK5VRKhvH-M4yaO7vN3m6Ddpufdpu7pud_rnHf8stfBPgeKFhCG_Pv2f-RvQWDH7l0</recordid><startdate>20220101</startdate><enddate>20220101</enddate><creator>Canosa, Stefano</creator><creator>Parmegiani, Lodovico</creator><creator>Charrier, Lorena</creator><creator>Gennarelli, Gianluca</creator><creator>Garello, Cristina</creator><creator>Granella, Francesca</creator><creator>Evangelista, Francesca</creator><creator>Monelli, Giuseppe</creator><creator>Guidetti, Daniela</creator><creator>Revelli, Alberto</creator><creator>Filicori, Marco</creator><creator>Bongioanni, Francesca</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-4390-9428</orcidid><orcidid>https://orcid.org/0000-0001-6402-6750</orcidid><orcidid>https://orcid.org/0000-0002-1300-4508</orcidid><orcidid>https://orcid.org/0000-0002-5797-3722</orcidid><orcidid>https://orcid.org/0000-0003-4995-0317</orcidid><orcidid>https://orcid.org/0000-0003-3901-885X</orcidid></search><sort><creationdate>20220101</creationdate><title>Are commercial warming kits interchangeable for vitrified human blastocysts? Further evidence for the adoption of a Universal Warming protocol</title><author>Canosa, Stefano ; Parmegiani, Lodovico ; Charrier, Lorena ; Gennarelli, Gianluca ; Garello, Cristina ; Granella, Francesca ; Evangelista, Francesca ; Monelli, Giuseppe ; Guidetti, Daniela ; Revelli, Alberto ; Filicori, Marco ; Bongioanni, Francesca</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-77772b4d8d345180c47d54f721a56f601656cdbe72f3bdee688c65ebebd8e7883</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Adult</topic><topic>Birth rate</topic><topic>Blastocysts</topic><topic>Blastomeres - cytology</topic><topic>Blastomeres - physiology</topic><topic>Cohort Studies</topic><topic>Cryopreservation</topic><topic>Embryo Transfer - methods</topic><topic>Embryology</topic><topic>Embryos</topic><topic>Female</topic><topic>Gynecology</topic><topic>Hot Temperature - therapeutic use</topic><topic>Human Genetics</topic><topic>Humans</topic><topic>In vitro fertilization</topic><topic>Laboratories</topic><topic>Longitudinal Studies</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>Oocytes - cytology</topic><topic>Oocytes - parasitology</topic><topic>Opinion</topic><topic>Ovaries</topic><topic>Pregnancy</topic><topic>Reproductive Medicine</topic><topic>Sperm</topic><topic>Survival</topic><topic>Vitrification</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Canosa, Stefano</creatorcontrib><creatorcontrib>Parmegiani, Lodovico</creatorcontrib><creatorcontrib>Charrier, Lorena</creatorcontrib><creatorcontrib>Gennarelli, Gianluca</creatorcontrib><creatorcontrib>Garello, Cristina</creatorcontrib><creatorcontrib>Granella, Francesca</creatorcontrib><creatorcontrib>Evangelista, Francesca</creatorcontrib><creatorcontrib>Monelli, Giuseppe</creatorcontrib><creatorcontrib>Guidetti, Daniela</creatorcontrib><creatorcontrib>Revelli, Alberto</creatorcontrib><creatorcontrib>Filicori, Marco</creatorcontrib><creatorcontrib>Bongioanni, Francesca</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of assisted reproduction and genetics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Canosa, Stefano</au><au>Parmegiani, Lodovico</au><au>Charrier, Lorena</au><au>Gennarelli, Gianluca</au><au>Garello, Cristina</au><au>Granella, Francesca</au><au>Evangelista, Francesca</au><au>Monelli, Giuseppe</au><au>Guidetti, Daniela</au><au>Revelli, Alberto</au><au>Filicori, Marco</au><au>Bongioanni, Francesca</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Are commercial warming kits interchangeable for vitrified human blastocysts? Further evidence for the adoption of a Universal Warming protocol</atitle><jtitle>Journal of assisted reproduction and genetics</jtitle><stitle>J Assist Reprod Genet</stitle><addtitle>J Assist Reprod Genet</addtitle><date>2022-01-01</date><risdate>2022</risdate><volume>39</volume><issue>1</issue><spage>67</spage><epage>73</epage><pages>67-73</pages><issn>1058-0468</issn><eissn>1573-7330</eissn><abstract>Purpose
To study whether a new combination of different warming kits is clinically effective for vitrified human blastocysts.
Methods
This is a longitudinal cohort study analysing two hundred fifty-five blastocysts warming cycles performed between January and October 2018. Embryos were vitrified using only one brand of ready-to-use kits (Kitazato), whereas the warming procedure was performed with three of the most widely used vitrification/warming kits (Kitazato, Sage and Irvine) after patient stratification for oocyte source. The primary endpoint was survival rate, while the secondary endpoints were clinical pregnancy, live birth and miscarriage rates.
Results
We observed a comparable survival rate across all groups of 100% (47/47) in KK, 97.6% (49/50) in KS, 97.6% (41/42) in KI, 100% (38/38) in dKK, 100% (35/35) in dKS and 100% (43/43) in dKI. Clinical pregnancy rates were also comparable: 38.3% (18/47) in KK, 49% (24/49) in KS, 56.1% (23/ 41) in KI, 47.4% (18/38) in dKK, 31.4% (11/35) in dKS and 48.8% (21/ 43) in dKI. Finally, live birth rates were 29.8% (14/47) in KK, 36.7% (18/49) in KS, 46.3% (19/41) in KI, 36.8% (14/38) in dKK, 25.7% (9/35) in dKS and 41.9% (18/43) in dKI, showing no significant differences.
Conclusion
This study confirmed the efficacy of applying a single warming protocol, despite what the “industry” has led us to believe, supporting the idea that it is time to proceed in the cryopreservation field and encouraging embryologists worldwide to come out and reveal that such a procedure is possible and safe.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>34845576</pmid><doi>10.1007/s10815-021-02364-1</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0003-4390-9428</orcidid><orcidid>https://orcid.org/0000-0001-6402-6750</orcidid><orcidid>https://orcid.org/0000-0002-1300-4508</orcidid><orcidid>https://orcid.org/0000-0002-5797-3722</orcidid><orcidid>https://orcid.org/0000-0003-4995-0317</orcidid><orcidid>https://orcid.org/0000-0003-3901-885X</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1058-0468 |
ispartof | Journal of assisted reproduction and genetics, 2022-01, Vol.39 (1), p.67-73 |
issn | 1058-0468 1573-7330 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8866604 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central; SpringerLink Journals - AutoHoldings |
subjects | Adult Birth rate Blastocysts Blastomeres - cytology Blastomeres - physiology Cohort Studies Cryopreservation Embryo Transfer - methods Embryology Embryos Female Gynecology Hot Temperature - therapeutic use Human Genetics Humans In vitro fertilization Laboratories Longitudinal Studies Male Medicine Medicine & Public Health Middle Aged Oocytes - cytology Oocytes - parasitology Opinion Ovaries Pregnancy Reproductive Medicine Sperm Survival Vitrification |
title | Are commercial warming kits interchangeable for vitrified human blastocysts? Further evidence for the adoption of a Universal Warming protocol |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T19%3A59%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Are%20commercial%20warming%20kits%20interchangeable%20for%20vitrified%20human%20blastocysts?%20Further%20evidence%20for%20the%20adoption%20of%20a%20Universal%20Warming%20protocol&rft.jtitle=Journal%20of%20assisted%20reproduction%20and%20genetics&rft.au=Canosa,%20Stefano&rft.date=2022-01-01&rft.volume=39&rft.issue=1&rft.spage=67&rft.epage=73&rft.pages=67-73&rft.issn=1058-0468&rft.eissn=1573-7330&rft_id=info:doi/10.1007/s10815-021-02364-1&rft_dat=%3Cproquest_pubme%3E2632034741%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2632034741&rft_id=info:pmid/34845576&rfr_iscdi=true |